Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Myeloid, Chronic-Phase 6Leukemia 5Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Blast Crisis 1

Interventions

Cyclophosphamide 47fludarabine phosphate 43Peripheral Blood Stem Cell Transplantation 40Busulfan 37Tacrolimus 34Methotrexate 30Antilymphocyte Serum 28Mycophenolic Acid 22Whole-Body Irradiation 21Radiotherapy 21Cyclosporine 21Methylprednisolone 17Melphalan 15Filgrastim 15Cytarabine 13Cord Blood Stem Cell Transplantation 13merphos 11Etoposide 10sargramostim 8Rituximab 8Thiotepa 7Sirolimus 6thymoglobulin 5Transplantation 5Interferon-alpha 5ponatinib 4Imatinib Mesylate 4Granulocyte Colony-Stimulating Factor 4CT-P10 4fludarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Myeloid, Accelerated Phase × Homoharringtonine × Clear all
NCT00114959 2015-01-15

Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
15 enrolled 6 charts
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡